Susan R. Goulding

LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease

Martina Mazzocchi, Susan R. Goulding, Séan Wyatt et al. · Molecular and Cellular Neuroscience · 2021 · 30 citations · Full text

Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson’s disease

Martina Mazzocchi, Susan R. Goulding, Noelia Morales‐Prieto et al. · Brain Behavior and Immunity · 2022 · 30 citations · Full text

Da Neurons, Neurodegenerative Diseases, Peripheral Administration +15

Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein

Susan R. Goulding, Aideen M. Sullivan, Gerard W. O’Keeffe et al. · Parkinsonism & Related Disorders · 2019 · 16 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Neurogenomics +14

STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5

Jayanth Anantha, Susan R. Goulding, Séan Wyatt et al. · iScience · 2020 · 15 citations · Full text

NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease

Jayanth Anantha, Susan R. Goulding, Eszter Tuboly et al. · Molecular Neurobiology · 2021 · 11 citations · Full text